• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » J&J’s DePuy is laying off 67 workers in Colorado

J&J’s DePuy is laying off 67 workers in Colorado

October 31, 2023 By Sean Whooley

DePuy Synthes Johnson & Johnson MedTech J&JJohnson & Johnson’s (NYSE: JNJ) DePuy Spine issued a WARN letter confirming 67 layoffs at a facility in Monument, Colorado.

The company issued the letter pursuant to the Worker Adjustment and Retraining Notification (WARN) Act. It decided to eliminate positions permanently at the facility located at 1101 Synthes Avenue, Monument, Colorado.

DePuy’s letter said the action comes as a result of a business decision. The company elected to permanently discontinue manufacturing, quality and distribution activities at the location. Employee separation comes over the course of a 14-day window. The state received the WARN letter on Oct. 30 and it says layoffs begin on Dec. 29, 2023.

Jobs affected by the layoffs include assembly/packaging, business solutions, facilities and manufacturing/production positions. The largest amount of employees affected — 41 — hold material/handling/distribution jobs. The layoffs also affect operations, process, process engineering, production maintenance, quality control/assurance and warehouse positions.

DePuy also executed 15 layoffs at the same plant in July and another 10 in August, according to the state of Colorado. These moves come as many companies in medtech have executed workforce reductions over the past year and more.

The latest batch of layoffs at DePuy also follows a shift in J&J’s management of its orthopedics business unit. Earlier this month, the company shared plans for a two-year restructuring program. It aims to take the orthopedics unit out of “less profitable markets and product lines” to improve the segment’s profitability.

There was news in March that J&J MedTech would lay off at least 1,000 employees in a reorganization effort.

Statement from J&J MedTech

A Johnson & Johnson MedTech spokesperson provided the following statement to MassDevice via email:

“We are continuously looking for opportunities to evolve and improve the way we operate. As part of that process, we evaluated our supply chain operations and began to migrate product supply from our Monument, CO facility to our Mooresville, IN distribution center in 2020.  We remain committed to supporting employees and partners during this time of change. This move will increase capacity for our inventory and enhance  supply chain operations in support of our customers and their patients.”

Filed Under: Business/Financial News, Featured, News Well, Orthopedic Implants, Orthopedics, Spine Tagged With: DePuy Synthes, Johnson & Johnson, Johnson & Johnson MedTech

More recent news

  • FDA warns of Philips ultrasound issues after four patient deaths
  • FDA approves Gore bridging stent graft in complex aortic aneurysms
  • Steris inks $2.1B deal for operating room supplier Xodus Medical
  • Insulet’s Omnipod Discover data platform begins full US rollout
  • Siemens Healthineers exits general ultrasound to focus on cardiac imaging

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy